Jiangxi Hongda Medical Equipment Group Co.

What Jiangxi Hongda Medical Equipment Group Co. does

Jiangxi Hongda Medical Equipment Group Co., Ltd. (江西洪达医疗器械集团有限公司) is a privately held Chinese manufacturer of single-use sterile medical devices, headquartered in Jinxian County, Nanchang, Jiangxi Province. The company originated in 1987 and was formally established as a group in 1995. It produces eight major product categories — syringes, infusion/blood sets, puncture instruments, examination instruments, anesthesia and catheter products, blood purification solutions, diagnostic reagents, and electronic medical equipment — under the "Hongda" (洪达) brand, with stated annual capacity of 40 billion units and approximately 25% domestic market share in single-use sterile medical devices in China.

The company operates a 600-acre manufacturing campus that includes 42,000 square meters of 100,000-class purification workshops, employs 3,600+ people, and holds registered capital of 428.88 million yuan with total assets of 20.98 billion yuan. Its technology base is built around automated sterile-device manufacturing, ISO 9001/ISO 13485 quality systems, and a portfolio of 11 international invention patents and 106+ utility model patents. The company is certified for global distribution, holding CE MDR, IVDR, FDA 510(k), WHO PQS, UKCA, EU PPE CE, and Russian medical device registrations, and exports to the Americas, Europe, Africa, the Middle East, and Southeast Asia alongside its domestic direct-sales operation.

Revenues are generated via hardware sales of medical consumables to three segments: healthcare providers (hospitals, clinics, medical centers), medical device distributors, and government healthcare procurement programs. Go-to-market combines a domestic marketing center for direct sales, an import-export subsidiary for global distribution, and an Alibaba International storefront. Pricing is not publicly disclosed and is handled through direct quotation. The company is led by Chairman Wang Jianghua (born 1981) and CEO Wang Haiyin, with multiple vice presidents overseeing the R&D center, production center, finance, procurement, and quality functions. Hongda is positioning for an upgrade into higher-value Class III devices, IVD, blood purification, and intelligent medical equipment under its "Hongda Hongyun Ten Billion Medical Industrial Park" plan, supported by a 320 million yuan R&D platform investment over five years.

Name

Jiangxi Hongda Medical Equipment Group Co.

Legal name

江西洪达医疗器械集团有限公司 (Jiangxi Hongda Medical Equipment Group Co., Ltd.)

Website

https://jxhd.cn

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Jiangxi Hongda Medical Equipment Group is a privately held Chinese manufacturer of single-use sterile medical devices — syringes, infusion sets, catheters, and diagnostics — holding roughly 25% domestic market share and supplying hospitals, distributors, and government health programs across China and five export regions.

Ownership category

akta.pro rank

Product category

Disposable Sterile Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

akta.pro secondary industry

Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB)

Keywords

• Disposable medical devices
• Sterile medical consumables
• Infusion sets
• Medical syringes
• Hemodialysis consumables

Headquarters

HQ city

Jiangxi

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Device Sales: Revenue generated from manufacturing and selling single-use sterile medical devices. Products include infusion sets, syringes, puncture equipment, examination equipment, anesthesia equipment, catheters, blood purification products, medical equipment, and diagnostic reagents across 10 major categories with hundreds of varieties.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Jiangxi Hongda Medical Equipment Group manufactures single-use sterile medical device consumables in eight major product categories — syringes, infusion/blood sets, puncture devices, examination devices, anesthesia products, catheters, blood purification (hemodialysis) consumables, and IVD/diagnostic reagents — plus electronic medical equipment and smart medical information management systems. The company produces approximately 4 billion units (sets) annually and holds about 25% of China's domestic market share for disposable sterile medical devices.

Differentiator

Problem solved

Functional benefit

Products and services

• Infusion and Blood Transfusion Sets (输液血器类) Single-use sterile infusion and blood transfusion sets for intravenous therapy and blood administration; for hospitals, clinics, and blood banks.
• Syringes (注射器类) Single-use sterile syringes for injection administration across clinical and pharmaceutical use; for hospitals, clinics, and vaccination programs.
• Puncture Devices (穿刺器械类) Single-use sterile puncture instruments (e.g., needles, biopsy and venous access puncture devices); for hospitals, clinics, and laboratory settings.
• Examination Devices (检查器械类) Single-use auxiliary examination devices used in clinical diagnostics and patient assessment; for hospitals and clinics.
• Anesthesia Catheter Products (麻醉导管类) Single-use sterile anesthesia catheter products for anesthesia administration and airway management; for hospital anesthesia departments, ICUs, and surgical theaters.
• Hemodialysis Consumables / Blood Purification Solutions (血液透析耗材类) Single-use sterile blood purification and hemodialysis consumables, providing an integrated blood purification solution; for dialysis centers and hospital nephrology departments.
• In Vitro Diagnostic (IVD) Reagents (诊断试剂类) In vitro diagnostic reagents for clinical chemistry, immunology, and other diagnostic testing applications; for hospital labs, diagnostic centers, and clinics.
• Electronic Medical Equipment (电子医疗设备类) Electronic medical hardware devices used in clinical settings; for hospitals and clinical departments as part of Hongda's broader medical device portfolio.
• Medical Protection Products (医用防护类) Single-use medical protective equipment (PPE) products for infection control, certified for EU (CE), United Kingdom (UKCA), and WHO PQS markets; for hospitals, public health agencies, and emergency response.
• Smart Medical Information Management (智慧医疗) Multi-modal smart medical information management products covering medical information systems and digital healthcare solutions; for hospitals and healthcare networks.

Quantifiable outcome

• 40 billion units annual production capacity
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• 中国医疗器械行业协会 (China Medical Device Industry Association)coreStrategic or Co-development PartnerHongda Group has been elected as a standing director unit of the association and vice chairman unit of Medical Polymer Products Branch, indicating significant industry standing and partnership in standards development.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Smiths Medical (ICU Medical): Global manufacturer of infusion therapy, syringes, and vascular access products (now part of ICU Medical). Comparable product portfolio overlapping Hongda's infusion, syringe, and catheter lines in international hospital and home-care markets.
• Nipro Corporation: Japanese manufacturer of medical devices including syringes, needles, and dialysis products (relevant to Hongda's blood purification line). Comparable as a global disposable medical device competitor with similar regulatory and export profile.
• Becton, Dickinson and Company (BD): Global leader in syringes, infusion therapy, and surgical disposables with a comprehensive medical device portfolio. Comparable product categories (syringes, infusion sets, catheters) and overlapping regulatory profile, though BD serves a much broader global market from established developed-market positions.
• Fresenius Kabi: Global supplier of infusion/transfusion products, syringes, and clinical nutrition overlapping directly with Hongda's infusion and blood collection lines. A relevant incumbent competing in international tenders where Hongda exports its FDA- and CE-marked disposables.
• Terumo Corporation: Japanese medical technology company with strong positions in syringes, blood bags, and infusion systems. Comparable as a global disposable medical device competitor, especially in Asia-Pacific and emerging markets where Hongda also competes for public hospital tenders.
• Lepu Medical Technology (Beijing) Co. Chinese medical device conglomerate spanning interventional cardiology, IVD, and disposables. Comparable as a domestic Chinese peer with a broader portfolio (IVD, devices) competing for hospital contracts and increasingly in the same IVD and Class III device space where Hongda is moving.
• B. Braun Melsungen AG: German medical device and pharmaceutical company with leading positions in infusion therapy, syringes, and clinical nutrition. Directly competes with Hongda in OEM/private-label infusion sets and competes in tenders where Hongda exports CE-marked disposables.

Direct peers

• Jiangsu Kanghui Medical Innovation Co. Chinese manufacturer of disposable medical devices including syringes, infusion sets, and blood collection tubes. Comparable as a smaller domestic peer competing in similar product categories and serving both domestic hospitals and export markets.
• Shanghai Kindly Enterprise Development Group: Specializes in safety syringes, hypodermic needles, and infusion sets, exporting globally with FDA 510(K) and CE certifications. Highly comparable as a China-based disposable needle/syringe/IV catheter peer competing for similar hospital and OEM contracts.
• Shandong Weigao Group Medical Polymer Co. China's largest domestic manufacturer of disposable medical consumables including infusion sets, syringes, and orthopedic products. Directly comparable to Hongda in product mix, target customers (Chinese hospitals), and export-driven business model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/jxhd

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jiangxi Hongda Medical Equipment Group Co.